What is Canton Strategic Holdings's market cap?

Canton Strategic Holdings (CNTN) has a market capitalization of $177.7M and trades on XNAS.

Who are Canton Strategic Holdings's competitors?

Canton Strategic Holdings's key competitors include MicroStrategy Incorporated, Marathon Digital Holdings, Inc., AbbVie Inc., and others. These companies compete in similar markets and product categories.

Who does Canton Strategic Holdings partner with?

Canton Strategic Holdings's notable partners include Canton Foundation, Intract Pharma Limited, Clear Street LLC, and others.

What subsidiaries does Canton Strategic Holdings have?

Canton Strategic Holdings's subsidiaries include Gravitas Life Sciences, Inc., HB Pharma Corp.

Where is Canton Strategic Holdings headquartered?

Canton Strategic Holdings is headquartered in United States of America. It has been publicly traded since 2022.

Canton Strategic Holdings (CNTN) Stock Fundamentals

Canton Strategic Holdings is a dual-sector company that manages a digital asset treasury focused on the Canton Network while developing clinical-stage biopharmaceutical candidates.

Market cap

$177.69M+0.3%

Net income-$80.7M-547%

EPS (diluted)-$2.20+76.7%

Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

August 14, 2026

Revenue$1.5M EPS$0.01

Read the full report

Next report

Date not yet announced

Financials

Q1 2026

Income statement

See full

Operating income-$36.9M-1,348%

Net income-$47.3M-1,763%

EPS (diluted)-$0.23+76.8%

Balance sheet

See full

Cash & equivalents$41.5M+3,760%

Total equity$469.8M+57,767%

Total assets$584.7M+35,093%

Cash flow

See full

Operating cash flow-$7.6M-184%

Competitors

By market cap

AbbVie$464.58B+26.4%

MicroStrategy$48.9B-49.5%

Marathon Digital Holdings$4.3B-26.2%

CNT

Canton Strategic Holdings$177.7M—

CYP

Cypherpunk Technologies$175.7M—

Verb Technology Company, Inc.$164.1M-82.0%

Solana Company$123.9M+1,759%

MEI Pharma$33.8M-79.8%

By revenue growth

Solana Company+3,992%

Verb Technology Company, Inc.+663%

AbbVie+10.4%

MicroStrategy+6.4%

Marathon Digital Holdings+0.7%

By net margin

AbbVie9.8%+3.3pp

Marathon Digital Holdings-430.23%-515pp

Verb Technology Company, Inc.-1,416.59%-986pp

MicroStrategy-1,624.27%-466pp

CYP

Cypherpunk Technologies-2,705.8%—

Solana Company-39,358.87%+347pp

Profile

Canton Strategic Holdings is a dual-sector company that manages a digital asset treasury focused on the Canton Network while developing clinical-stage biopharmaceutical candidates. The company leverages its strategic reserve of Canton Coin to support institutional blockchain adoption and financial market digitization, while simultaneously advancing therapeutic programs for inflammatory and immunologic conditions.

Competitive position

The company is the first publicly traded entity to specifically leverage Canton Coin and participate in the governance of the Canton Network while maintaining a legacy clinical-stage biotech pipeline.

GeographiesUnited States, Global

Customer segmentsInstitutional investors, Healthcare providers, Government agencies

Business modelAsset management, Infrastructure-as-a-Service, Research and development

SuppliersInstitutional-grade digital asset custodians, Contract Manufacturing Organizations (CMOs), Canton Foundation, Academic research institutions

CustomersInstitutional blockchain users, Pharmaceutical commercialization partners, Military and emergency medical services

CountryUnited States of America

Listed2022

CEOMark Wendland

SectorHealthcare

IndustryBiotechnology

Websitecantonstrategic.com

FilingsSEC EDGAR

FAQ

What is Canton Strategic Holdings's market cap?: Canton Strategic Holdings (CNTN) has a market capitalization of $177.7M and trades on XNAS.
Who are Canton Strategic Holdings's competitors?: Canton Strategic Holdings's key competitors include MicroStrategy Incorporated, Marathon Digital Holdings, Inc., AbbVie Inc., and others. These companies compete in similar markets and product categories.
Who does Canton Strategic Holdings partner with?: Canton Strategic Holdings's notable partners include Canton Foundation, Intract Pharma Limited, Clear Street LLC, and others.
What subsidiaries does Canton Strategic Holdings have?: Canton Strategic Holdings's subsidiaries include Gravitas Life Sciences, Inc., HB Pharma Corp.
Where is Canton Strategic Holdings headquartered?: Canton Strategic Holdings is headquartered in United States of America. It has been publicly traded since 2022.